TAS 102

Clinical trials for TAS 102 explained in plain language.

Never miss a new study

Get alerted when new TAS 102 trials appear

Sign up with your email to follow new studies for TAS 102, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

New combo therapy trial offers hope for elderly esophageal cancer patients

Disease control Not yet recruiting

This study is testing whether combining a cancer drug called TAS-102 with radiation therapy is safe and effective for older adults with advanced esophageal cancer. The first part finds the safest dose, and the second part checks how well that dose works to control the cancer. The…

Matched conditions: TAS 102

Phase: PHASE1, PHASE2 • Sponsor: Qianfoshan Hospital • Aim: Disease control

Last updated Mar 30, 2026 14:32 UTC

TAS 102

Get alerted when new TAS 102 trials appear

New combo therapy trial offers hope for elderly esophageal cancer patients